No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹774Prev. Close
₹733.15Turnover(Lac.)
₹14,147.51Day's High
₹806.45Day's Low
₹735.352 Week's High
₹838.852 Week's Low
₹409.3Book Value
₹157.14Face Value
₹2Mkt Cap (₹ Cr.)
11,980.04P/E
98.85EPS
7.4Divi. Yield
0.414 May 2026
12:00 AM
AGM
Announcement Date: 14 May, 2026
28 Oct 2026
12:00 AM
Board Meeting
Agenda : Audited Result
14 May 2026
12:00 AM
Dividend
Dividend Amount: 1
Record Date: 03 Jul, 2026
The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.
The IPO comprised a fresh issue of shares worth ₹680 crore and an offer-for-sale (OFS) of 1.73 crore shares, aggregating ₹1,177 crore.
The IPO consists of a fresh issue of ₹680 crore and an offer for sale (OFS) of up to 1.73 crore shares at a face value of ₹2 each.
On Monday, the business said that it had received ₹829 crore from anchor investors ahead of the public share sale subscription period.
The IPO includes a new issue of 1 Crore shares worth ₹680.00 Crore and an offer for sale of 1.73 Crore shares worth ₹1,176.74 Crore.
| Y/e 31 Mar( In .Cr) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 |
|---|---|---|---|---|
Equity Capital | 30.62 | 30.62 | 28.61 | 28.61 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 2,396.95 | 2,274.63 | 115.27 | 282.89 |
Net Worth | 2,427.57 | 2,305.25 | 143.88 | 311.5 |
Minority Interest |
No Record Found
No Record Found
No Record Found
| Particulars (Rupees in Crores.) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
Gross Sales | 4,359.02 | 4,118.16 | 4,178.18 | 3,654.82 | 3,671.89 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 4,359.02 | 4,118.16 | 4,178.18 | 3,654.82 | 3,671.89 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 128.73 | 68.82 | 34.03 | 46.11 | 22.83 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,769.9 | 121.51 | 4,24,202.42 | 871.29 | 0.9 | 6,056.59 | 97.38 |
Divis Laboratories Ltd DIVISLAB | 10,064 | 88.17 | 2,64,141.24 | 891 | 0.3 | 2,974 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,650 | 89.5 | 1,74,402.47 | 498 | 0.74 | 4,063 | 479.96 |
Laurus Labs Ltd LAURUSLABS | 2,323 | 121.35 | 1,26,811.28 | 388.13 | 0.09 | 2,014.11 | 108.87 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,240.6 | 33.93 | 1,23,685.49 | 339.6 | 0.08 | 2,723.5 | 237.3 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
ED / MD / Promoter
SANJEEV JAIN
ED / MD / Promoter
SANDEEP JAIN
Whole-time Director
Sanjay Sinha
Independent Non Exe. Director
Kewal Handa
Independent Non Exe. Director
Matangi Gowrishankar
Independent Non Exe. Director
SATWINDER SINGH
Non-Exec & Non-Independent Dir
SUNIL KUMAR THAKUR
Independent Non Exe. Director
Anil Kumar Arvindlal Amin
Company Sec. & Compli. Officer
DHARAMVIR MALIK
304 Mohan Place LSC Saraswati,
Vihar,
Delhi - 110034
Tel: +91 11 6904 1000
Website: http://www.akums.in
Email: cs@akums.net
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: https://in.mpms.mufg.com
Email: rnt.helpdesk@in.mpms.mufg.com
Summary
Akums Drugs and Pharmaceuticals Limited was incorporated vide Certificate of Incorporation dated April 19, 2004 and received a Certificate for Commencement of Business dated May 13, 2004 issued by the...
Read More
Reports by Akums Drugs & Pharmaceuticals Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
